Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1992 1
1993 1
1994 1
1995 1
1996 2
1997 1
1998 3
1999 3
2000 4
2001 2
2002 5
2003 4
2004 6
2005 6
2006 8
2007 11
2008 16
2009 12
2010 12
2011 14
2012 10
2013 18
2014 14
2015 9
2016 22
2017 17
2018 17
2019 18
2020 11
2021 17
2022 14
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Results by year

Filters applied: . Clear all
Page 1
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P. Hiemke C, et al. Among authors: grunder g. Pharmacopsychiatry. 2018 Jan;51(1-02):9-62. doi: 10.1055/s-0043-116492. Epub 2017 Sep 14. Pharmacopsychiatry. 2018. PMID: 28910830 Free article. Review.
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P. Hiemke C, et al. Among authors: grunder g. Pharmacopsychiatry. 2018 Jan;51(1-02):e1. doi: 10.1055/s-0037-1600991. Epub 2018 Feb 1. Pharmacopsychiatry. 2018. PMID: 29390205 No abstract available.
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Seppälä N, Kopeček M, Švancer P, Olmos I, Ricciardi C, Iglesias-Garcia C, Iglesias-Alonso A, Spina E, Ruan CJ, Wang CY, Wang G, Tang YL, Lin SK, Lane HY, Kim YS, Kim SH, Rajkumar AP, González-Esquivel DF, Jung-Cook H, Baptista T, Rohde C, Nielsen J, Verdoux H, Quiles C, Sanz EJ, De Las Cuevas C, Cohen D, Schulte PFJ, Ertuğrul A, Anıl Yağcıoğlu AE, Chopra N, McCollum B, Shelton C, Cotes RO, Kaithi AR, Kane JM, Farooq S, Ng CH, Bilbily J, Hiemke C, López-Jaramillo C, McGrane I, Lana F, Eap CB, Arrojo-Romero M, Rădulescu FŞ, Seifritz E, Every-Palmer S, Bousman CA, Bebawi E, Bhattacharya R, Kelly DL, Otsuka Y, Lazary J, Torres R, Yecora A, Motuca M, Chan SKW, Zolezzi M, Ouanes S, De Berardis D, Grover S, Procyshyn RM, Adebayo RA, Kirilochev OO, Soloviev A, Fountoulakis KN, Wilkowska A, Cubała WJ, Ayub M, Silva A, Bonelli RM, Villagrán-Moreno JM, Crespo-Facorro B, Temmingh H, Decloedt E, Pedro MR, Takeuchi H, Tsukahara M, Gründer G, Sagud M, Celofiga A, Ignjatovic Ristic D, Ortiz BB, Elkis H, Pacheco Palha AJ, LLerena A, Fernandez-Egea E, Siskind D, Weizman A, Masmoudi R, Mohd Saffian S, Leung JG, Buckley PF, Marder SR… See abstract for full author list ➔ de Leon J, et al. Among authors: grunder g. Pharmacopsychiatry. 2022 Mar;55(2):73-86. doi: 10.1055/a-1625-6388. Epub 2021 Dec 15. Pharmacopsychiatry. 2022. PMID: 34911124 Free article.
[Neuroenhancement].
Gründer G, Bartsch T. Gründer G, et al. Nervenarzt. 2014 Dec;85(12):1536-43. doi: 10.1007/s00115-013-3977-3. Nervenarzt. 2014. PMID: 25403289 Review. German.
Psilocybin for Depression.
Gründer G, Mertens L. Gründer G, et al. N Engl J Med. 2021 Aug 26;385(9):863. doi: 10.1056/NEJMc2108082. N Engl J Med. 2021. PMID: 34437797 No abstract available.
[Are psychedelics fast acting antidepressant agents?].
Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M, Mertens LJ. Gründer G, et al. Nervenarzt. 2022 Mar;93(3):254-262. doi: 10.1007/s00115-021-01255-1. Epub 2022 Feb 1. Nervenarzt. 2022. PMID: 35103814 Review. German.
The downside of downregulation.
Gründer G, Cumming P. Gründer G, et al. Brain. 2019 Jun 1;142(6):1500-1502. doi: 10.1093/brain/awz133. Brain. 2019. PMID: 31135045 Free article. No abstract available.
[Digital phenotyping. Contra].
Gründer G. Gründer G. Nervenarzt. 2020 Sep;91(9):860-862. doi: 10.1007/s00115-020-00902-3. Nervenarzt. 2020. PMID: 32236664 German. No abstract available.
Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis.
Hart XM, Hiemke C, Eichentopf L, Lense XM, Clement HW, Conca A, Faltraco F, Florio V, Grüner J, Havemann-Reinecke U, Molden E, Paulzen M, Schoretsanitis G, Riemer TG, Gründer G. Hart XM, et al. Among authors: grunder g. Psychopharmacology (Berl). 2022 Nov;239(11):3377-3391. doi: 10.1007/s00213-022-06233-2. Epub 2022 Oct 5. Psychopharmacology (Berl). 2022. PMID: 36195732 Free PMC article. Review.
Treatment with psychedelics is psychotherapy: beyond reductionism.
Gründer G, Brand M, Mertens LJ, Jungaberle H, Kärtner L, Scharf DJ, Spangemacher M, Wolff M. Gründer G, et al. Lancet Psychiatry. 2024 Mar;11(3):231-236. doi: 10.1016/S2215-0366(23)00363-2. Epub 2023 Dec 12. Lancet Psychiatry. 2024. PMID: 38101439 Review.
246 results